Pancreatic Cancer Research

ResearcherTang Du HospitalActive in the last 2 years

Gang Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5842-8080; OpenAlex author ID A5100367389. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 4

  1. Preoperative evaluating early recurrence in resectable pancreatic ductal adenocarcinoma by using CT radiomics. Co-author DOI 10.1007/s00261-023-04074-x↗
  2. Retraction Note to: Lupeol inhibits proliferation and induces apoptosis of human pancreatic cancer PCNA-1 cells through AKT/ERK pathways. Co-author DOI 10.1007/s00210-021-02113-2↗
  3. Increased expression of calponin 2 is a positive prognostic factor in pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.17701↗
  4. Lupeol inhibits proliferation and induces apoptosis of human pancreatic cancer PCNA-1 cells through AKT/ERK pathways. Co-author DOI 10.1007/s00210-014-1071-4↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hongyuan Shi · 1 shared paper, 2024 · strength 0.28
  2. Genhai Shen · 2 shared papers, 2015–2021 · strength 0.19
  3. Yan Liu · 1 shared paper, 2021 · strength 0.14
  4. Jiayu Liu · 1 shared paper, 2017 · strength 0.06
  5. Kaichun Wu · 1 shared paper, 2017 · strength 0.06
  6. Zhaoyan Qiu · 1 shared paper, 2017 · strength 0.06
  7. Jie Liang · 1 shared paper, 2017 · strength 0.06
  8. Yan Liu · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.